Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Apple stock at a crossroads, is now the time to buy?: https://www.marketbeat.com/logos/articles/med_20240108074512_apple-stock-at-a-crossroads-is-now-the-time-to-buy.jpg
Apple stock at a crossroads, is now the time to buy?

Apple Inc. (NASDAQ: AAPL) stands as a towering figure in the world of stocks and investments, a testament to the power of innovation and resilience in the tech industry. However, recent price

Bank of America and Citigroup are banking stocks that could soar: https://www.marketbeat.com/logos/articles/med_20240108073632_bank-of-america-and-citigroup-are-banking-stocks-c.jpg
Bank of America and Citigroup are banking stocks that could soar

Who likes to invest in financial stocks? Only people with a solid financial or accounting background, since they can reasonably understand the balance sheets and valuations of these stocks well

2 low-priced gene therapy stocks to speculate on: https://www.marketbeat.com/logos/articles/med_20240107112838_chart-sgmo.jpg
2 low-priced gene therapy stocks to speculate on

Gene therapy differs from gene editing, which is getting the lion's share of headlines. While gene editing is a form of gene therapy, there are basic differences. Gene-editing involves using

3 Magnificent Seven stocks are approaching potential buy zones: https://www.marketbeat.com/logos/articles/med_20240107184322_3-magnificent-seven-stocks-are-approaching-potenti.jpg
3 Magnificent Seven stocks are approaching potential buy zones

As the year begins and capital begins to be put to work, a new chapter is unfolding for members of the heralded 'Magnificent Seven.' As the curtains rise in 2024, these tech behemoths, the guiding

Eilt: Ausbruch - Massives Kaufsignal - Hautkrebs vollständig geheilt. Neuer 200% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73176/AC-080124.001.png
Eilt: Ausbruch - Massives Kaufsignal - Hautkrebs vollständig geheilt. Neuer 200% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Eilt: Ausbruch - Massives Kaufsignal - Hautkrebs vollständig geheilt. 200% Biotech Hot Stock nach 134.452% mit Biogen

 

08.01.24 08:03

AC Research

 

London (www.aktiencheck.de , Anzeige)

 

This biotech stock has surged over 300% this week: https://www.marketbeat.com/logos/articles/med_20240105071140_this-biotech-stock-has-surged-over-300-this-week.jpg
This biotech stock has surged over 300% this week

As the market continues to witness a resurgence in small-cap investments, led by a jump in investor optimism and speculation, there’s been a seemingly steady flow of capital back into

Will the Biotech sector sustain its momentum in 2024?: https://www.marketbeat.com/logos/articles/med_20240104092418_will-the-biotech-sector-sustain-its-momentum-in-20.jpg
Will the Biotech sector sustain its momentum in 2024?

The stock market is like a bustling stage, and on the first trading day of the year, one performer stole the show while others struggled to keep up. 

The iShares Biotechnology ETF (NASDAQ: IBB)

Is Netflix stock a buy ahead of January earnings?: https://www.marketbeat.com/logos/articles/med_20240104083945_is-netflix-stock-a-buy-ahead-of-january-earnings.jpg
Is Netflix stock a buy ahead of January earnings?

Even though a 75% drop through 2022 may have disqualified Netflix Inc (NASDAQ: NFLX) from the previously untouchable FAANG group of tech stocks, the current rally of nearly 200% has certainly put

3 ways to trade options if you believe a stock will fall lower: https://www.marketbeat.com/logos/articles/med_20240103120548_intcstock.jpg
3 ways to trade options if you believe a stock will fall lower

If you believe that a stock is going to fall lower in price, then there are three kinds of options trades you can make to capitalize on the move potentially. You don't necessarily have to be a

Starbucks stock is suddenly surrounded by analysts: https://www.marketbeat.com/logos/articles/med_20240103104020_starbucks-stock-is-suddenly-surrounded-by-analysts.jpg
Starbucks stock is suddenly surrounded by analysts

The answer everyone is looking for in today's market is one that potentially positions portfolios in a way to benefit from the coming FED interest rate cuts in 2024. Because markets are

UniFirst stock falls into the buy zone: https://www.marketbeat.com/logos/articles/med_20240103094647_chart-unf-132023ver001.png
UniFirst stock falls into the buy zone

UniFirst (NYSE: UNF) had a decent first quarter but provided weak guidance, sending shares down nearly 10%. As bad as the move sounds, it’s a knee-jerk reaction in a stock whose future is bright

5 Reasons Under Armour stock may not trade under $10 for long: https://www.marketbeat.com/logos/articles/med_20240103085353_5-reasons-under-armour-stock-may-not-trade-under-1.jpg
5 Reasons Under Armour stock may not trade under $10 for long

On two occasions last year, Under Armour, Inc. (NYSE:UAA) came within pennies of recovering to the $10.00 level. In 2024, the third time may not only be the charm but also unleash an extra large

4 takeaways from the first day of trading in 2024: https://www.marketbeat.com/logos/articles/med_20240103081547_chart-spx-132024ver001.png
4 takeaways from the first day of trading in 2024

The first day of 2024 trading has come and gone, and the signs they sent are not good. Between market leaders confirming a top, the S&P 500 (NYSEARCA: SPY) retreating, and the VIX (NDEXCBOE: VIX)

Intel stock: Analysts are expecting multi-year highs: https://www.marketbeat.com/logos/articles/med_20240103075306_intel-stock-analysts-are-expecting-multi-year-high.jpg
Intel stock: Analysts are expecting multi-year highs

After falling more than 50% in 2022, last year really was all about the recovery for shares of Intel Corporation (NASDAQ: INTC). They climbed throughout the year, finishing up about 100% from

Traders are suddenly stampeding these Buffett stocks: https://www.marketbeat.com/logos/articles/med_20240102191321_traders-are-suddenly-stampeding-these-buffett-stoc.jpg
Traders are suddenly stampeding these Buffett stocks

The new year is here, and some are already calling the shots about how 2024 could look. Who dominates? It will likely experience a 'trader' market in the first quarter of 2024, considering where

AT&T could be the best placeholder stock before rate cuts come: https://www.marketbeat.com/logos/articles/med_20240102190745_att-could-be-the-best-placeholder-stock-before-rat.jpg
AT&T could be the best placeholder stock before rate cuts come

A significant shift is about to come to the financial markets, as the forces that push and pull stock prices are pivoting from one end to the opposite in the coming months. Interest rates act as a

Will cost cuts be enough for Hasbro to thrive in 2024?: https://www.marketbeat.com/logos/articles/med_20231231120706_chartt-has.jpg
Will cost cuts be enough for Hasbro to thrive in 2024?

Global toy and entertainment company Hasbro Inc. (NYSE: HAS) had a weak 2023 as shares fell 17.5% compared to the 24.8% gain for the S&P 500 index. It also underperformed rival Mattel Inc. (NYSE:

Eilt: Biotech Hot Stock 2024 heilt Hautkrebs vollständig - Massives Kaufsignal. 297% Biotech Aktientip nach 134.452% mit Biogen. Massives Kaufsignal. Jetzt 359% mit Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205: https://www.irw-press.at/prcom/images/messages/2024/73150/Aktiencheck030124.001.png
Eilt: Biotech Hot Stock 2024 heilt Hautkrebs vollständig - Massives Kaufsignal. 297% Biotech Aktientip nach 134.452% mit Biogen. Massives Kaufsignal. Jetzt 359% mit Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205

Eilt: Biotech Hot Stock 2024 heilt Hautkrebs vollständig - Kaufsignal. 297% Biotech Aktientip nach 15.973% mit BioNTech

 

03.01.24

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

 

Link

Analysts suddenly say Google is the place to be in: https://www.marketbeat.com/logos/articles/med_20240102074605_analysts-suddenly-say-google-is-the-place-to-be-in.jpg
Analysts suddenly say Google is the place to be in

Very few times in history have investors come across a stock that offers the sort of moat that Warren Buffett could salivate over, a strong business with solid financials and a structure

One fast-food stock is expected to outperform all others in 2024: https://www.marketbeat.com/logos/articles/med_20240102074256_one-fast-food-stock-is-expected-to-outperform-all.jpg
One fast-food stock is expected to outperform all others in 2024

With a 20% rally under its belt since October, it goes without saying that McDonald's Corp (NYSE: MCD) is coming into 2024 looking pretty hot. After a disappointing Q3 threatened to spiral out of

PepsiCo's dividend won't last long in today's market: https://www.marketbeat.com/logos/articles/med_20240101143450_pepsicos-dividend-wont-last-long-in-todays-market.jpg
PepsiCo's dividend won't last long in today's market

Markets shift according to a straightforward selection process; as money becomes interested in better instruments or investments, money as a whole begins to rotate into different areas of the

4 reasons to buy Dutch Bros stock over Starbucks: https://www.marketbeat.com/logos/articles/med_20231231121354_chart-bros2.jpg
4 reasons to buy Dutch Bros stock over Starbucks

Drive-thru coffee and beverage operator Dutch Bros Inc. (NASDAQ: BROS) stock has more upside than the incumbent behemoth Starbucks Co. (NASDAQ: SBUX) on a percentage basis. Its newly minted CEO

New price targets could erase Cisco's 3.1% dividend yield soon: https://www.marketbeat.com/logos/articles/med_20240101140630_new-price-targets-could-erase-ciscos-3.jpg
New price targets could erase Cisco's 3.1% dividend yield soon

A new FED has come into play to end 2023 with a major surprise for most investors out there trying to find a direction to bet on and the implications this new view has are plenty, but today, you